Is Intensity Therapeutics Stock a good buy in 2024, according to Wall Street analysts?
The consensus among 1 Wall Street analyst covering (NASDAQ: INTS) stock is to Buy INTS stock.
Out of 1 analyst, 0 (0%) are recommending INTS as a Strong Buy, 1 (100%) are recommending INTS as a Buy, 0 (0%) are recommending INTS as a Hold, 0 (0%) are recommending INTS as a Sell, and 0 (0%) are recommending INTS as a Strong Sell.
According to 1 Wall Street analyst that have issued a 1 year INTS price target, the average INTS price target is $12.00, with the highest INTS stock price forecast at $12.00 and the lowest INTS stock price forecast at $12.00.
The Wall Street analyst predicted that Intensity Therapeutics's share price could reach $12.00 by Mar 21, 2025. The average Intensity Therapeutics stock price prediction forecasts a potential upside of 207.69% from the current INTS share price of $3.90.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.